JAMA Network
About The Study: Researchers found in this study that among Medicare beneficiaries initiating opioid use disorder-related care during the COVID-19 pandemic, receipt of opioid use disorder-related telehealth services was associated with reduced risk for fatal drug overdose, as was receipt of medications for opioid use disorder from opioid treatment programs and receipt of buprenorphine in office-based settings.
Authors: Christopher M. Jones, Pharm.D., Dr.P.H., M.P.H., of the Centers for Disease Control and Prevention in Atlanta, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(10.1001/jamapsychiatry.2023.0310)
/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.
